Brimonidine Tartrate Solution/ Drops
Product Images NDC 14445-400

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Brimonidine Tartrate (NDC 14445-400). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Indoco Remedies Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Str (Active)

Chemical structure of Brimonidine Tartrate, showing its molecular components including nitrogen-containing rings and functional groups, depicted with chemical bonds and atom labels. The diagram illustrates the compound's arrangement used in this ophthalmic solution product by Indoco Remedies Limited.*

FDA Label Image

Cart5ml (Cart5ml)

Brimonidine Tartrate Ophthalmic Solution 0.2% sterile eye drops in a 5 mL bottle, labeled for use in the eyes only. The packaging includes active and inactive ingredient information, usage instructions to instill one drop three times daily, storage conditions, and manufacturer details for Indoco Remedies Limited. The product NDC 14445-400-05 is marked Rx only.*

FDA Label Image

Logo (Logo)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.